Wikipedia -WSS

Wikipedia

author：explore 2025-09-03 15:21:52 - browse：9

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： There's no autism epidemic. It's an autism diagnosis epidemic

hotspot

WSS

Novo: Oral version of Ozempic leads to 15% weight loss

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Washington mulls new rules to avert another Change Healthcare

Abortion pill Supreme Court ruling could impact entire drug industry

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Will generative AI in health care meet the fate of IBM's Dr. Watson?

hotspot

Wikipedia

knowledge

Affirmative action in medical school literally saved lives

Eli Lilly’s Mounjaro succeeds in second weight

Anesthesiologist group: stop taking Ozempic before surgery

Abortion pill case raises question: who can sue the FDA?

Novavax promises a turnaround & Lilly roils the obesity market

FDA's naming rule on biosimilars has undermined competition

Continuity nursing helped my family in our darkest PICU moments

Novo pauses ads for weight loss drug Wegovy amid demand

DIEP, the 'gold standard' of breast reconstruction, is under threat

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

focus

Readout LOUD podcast: mifepristone case, GLP

Patients, doctors are clashing about side effects of hormonal birth control

FDA's naming rule on biosimilars has undermined competition

Patients, doctors are clashing about side effects of hormonal birth control

Scientists boost immune system in aging mice by making it youthful

Altering the blood type of lungs raises potential for universal organs for transplants

hotspot

hotspot

hotspot

hotspot